Plain-English translation of NCT06105580 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests two different pacemaker implant strategies for people with severe heart failure. One approach, called conduction system pacing, targets the heart's natural electrical pathways. The other, called biventricular pacing, uses leads placed in two different chambers. Researchers want to see which approach works better at reducing deaths, preventing hospitalizations, and helping people feel better.
Current pacemaker treatments for severe heart failure work well for many patients, but not everyone responds equally. This trial exists because early research suggests the newer conduction system pacing approach might work just as well—or even better—than the standard biventricular method, and doctors need to know which is best.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive one of the two pacemaker implant approaches. You will undergo the pacemaker procedure and then have follow-up visits over 12 months, including heart tests (echocardiograms), electrical heart tracings (EKGs), and clinic visits to check how you're doing. The study team will measure your heart function, hospitalizations, and overall health to compare how well each pacemaker approach works for you.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Spain